Clinical trial

A Study of the Effect on Pain Control of Treatment With Fentanyl, Administered…

NCT00236366 · Janssen Pharmaceutica N.V., Belgium, Industry · Completed

Key facts

NCT number NCT00236366
Title A Study of the Effect on Pain Control of Treatment With Fentanyl, Administered Through the Skin, Compared With Placebo in Patients With Osteoarthritis
Official title Randomised, Double-Blind, Placebo-Controlled, Parallel-Group, Multicentre Trial To Investigate Durogesic™ In Comparison To Placebo In Subjects With Moderate To Severe Pain Induced By Osteoarthritis Of The Hip Or The Knee, Who Are In Need Of And Waiting For Hip Or Knee Replacement.
Lead sponsor Janssen Pharmaceutica N.V., Belgium, Industry
Status Completed
Phase Phase 4
Study type Interventional
Conditions Osteoarthritis, Arthritis
Intervention type Drug
Interventions fentanyl
Enrollment 418
Start date Jun 1, 2002
Completion Apr 1, 2004
First posted Oct 12, 2005
Last update posted May 17, 2011

At a glance

  • No Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies